Generic-Drug Venture Backed by Hospitals Taps CEO From Amgen

(Bloomberg) -- A drugmaking venture backed by major U.S. hospitals has picked a chief executive officer, hastening the arrival of another threat to generic pharmaceutical manufacturers.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.